Related Experiment Videos
[Ketotifen in allergic diseases].
1Servicio de Alergia, Instituto Nacional de Pediatría.
Revista Alergia : Organo Oficial De La Sociedad Mexicana De Alergia E Inmunlogia
|November 1, 1991
Summary
Ketotifen effectively treated allergic diseases in 84% of pediatric patients, demonstrating good tolerance. This retrospective review analyzed 1000 cases of conditions like asthma and atopic dermatitis.
Area of Science:
- Allergy and Immunology
- Pediatric Medicine
- Clinical Pharmacology
Context:
- Retrospective analysis of 1000 pediatric allergy cases at a national institute in Mexico City.
- Patients diagnosed with various allergic pathologies including bronchial asthma, rhinitis, and atopic dermatitis.
- Focus on therapeutic outcomes of ketotifen treatment.
Purpose:
- To evaluate the efficacy and tolerance of ketotifen in treating a spectrum of allergic diseases in children.
- To assess the global improvement rates associated with ketotifen therapy.
- To document the safety profile of ketotifen in a pediatric population.
Summary:
- Ketotifen treatment for 3-12 months resulted in an 84% global improvement rate across all studied allergic pathologies.
- The study encompassed diverse allergic conditions such as asthma, rhinitis, and atopic dermatitis.
- Ketotifen exhibited very good tolerance, particularly in pediatric patients.
Impact:
- Provides evidence for ketotifen's significant efficacy in managing pediatric allergic diseases.
- Highlights ketotifen as a well-tolerated therapeutic option for childhood allergies.
- Contributes to understanding treatment outcomes in a large cohort of allergic children.